Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.

@article{Sabbah2002RanolazineAP,
  title={Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.},
  author={H. Sabbah and Margaret P. Chandler and Takayuki Mishima and G. Suzuki and P. Chaudhry and O. Nass and B. Biesiadecki and B. Blackburn and A. Wolff and W. Stanley},
  journal={Journal of cardiac failure},
  year={2002},
  volume={8 6},
  pages={
          416-22
        }
}
  • H. Sabbah, Margaret P. Chandler, +7 authors W. Stanley
  • Published 2002
  • Medicine
  • Journal of cardiac failure
  • BACKGROUND Abnormalities of energy metabolism are often cited as key elements in the progressive worsening of left ventricular (LV) dysfunction that characterizes the heart failure (HF) state. The present study tested the hypothesis that partial inhibition of fatty acids will ameliorate the hemodynamic abnormalities associated with HF. METHODS AND RESULTS Chronic HF (LV ejection fraction 27 +/- 1%) was produced in 13 dogs by intracoronary microembolizations. Hemodynamic and angiographic… CONTINUE READING
    119 Citations
    Ranolazine, an Inhibitor of the Late Sodium Channel Current, Reduces Postischemic Myocardial Dysfunction in the Rabbit
    • S. Hale, R. Kloner
    • Medicine
    • Journal of cardiovascular pharmacology and therapeutics
    • 2006
    • 51
    Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
    • 89
    • PDF
    Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation.
    • 118
    • PDF
    Ranolazine: new approach for the treatment of stable angina pectoris
    • W. Stanley
    • Medicine
    • Expert review of cardiovascular therapy
    • 2005
    • 14
    Role of ranolazine in angina, heart failure, arrhythmias, and diabetes.
    • 81
    • Highly Influenced
    Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure
    • G. Fragasso
    • Medicine
    • International journal of clinical practice
    • 2007
    • 21

    References

    SHOWING 1-10 OF 40 REFERENCES
    Modification of left ventricular hypertrophy by chronic etomoxir treatment
    • 46
    Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs.
    • O. Mjøs
    • Medicine, Chemistry
    • The Journal of clinical investigation
    • 1971
    • 261
    • PDF